This HTML5 document contains 36 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
n2http://linked.opendata.cz/resource/drugbank/drug/
dctermshttp://purl.org/dc/terms/
n14http://linked.opendata.cz/resource/drugbank/drug/DB07800/identifier/pubchem-compound/
n11http://linked.opendata.cz/resource/drugbank/drug/DB07800/identifier/pubchem-substance/
n7http://linked.opendata.cz/resource/drugbank/drug/DB07800/identifier/drugbank/
n9http://bio2rdf.org/drugbank:
admshttp://www.w3.org/ns/adms#
n4http://linked.opendata.cz/resource/drugbank/drug/DB07800/identifier/chemspider/
n12http://wifo5-03.informatik.uni-mannheim.de/drugbank/resource/drugs/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
owlhttp://www.w3.org/2002/07/owl#
n5http://linked.opendata.cz/ontology/drugbank/
n6http://linked.opendata.cz/resource/drugbank/property/
xsdhhttp://www.w3.org/2001/XMLSchema#
n13http://linked.opendata.cz/resource/drugbank/drug/DB07800/identifier/pdb/

Statements

Subject Item
n2:DB07800
rdf:type
n5:Drug
n5:group
experimental
owl:sameAs
n9:DB07800 n12:DB07800
dcterms:title
N-(2-(((5-CHLORO-2-PYRIDINYL)AMINO)SULFONYL)PHENYL)-4-(2-OXO-1(2H)-PYRIDINYL)BENZAMIDE
adms:identifier
n4:22377200 n7:DB07800 n11:99444271 n13:FXA n14:24794406
n5:IUPAC-Name
n6:271B405B-363D-11E5-9242-09173F13E4C5
n5:InChI
n6:271B4061-363D-11E5-9242-09173F13E4C5
n5:Molecular-Formula
n6:271B4060-363D-11E5-9242-09173F13E4C5
n5:Molecular-Weight
n6:271B405D-363D-11E5-9242-09173F13E4C5
n5:Monoisotopic-Weight
n6:271B405E-363D-11E5-9242-09173F13E4C5
n5:SMILES
n6:271B405F-363D-11E5-9242-09173F13E4C5
n5:Water-Solubility
n6:271B4059-363D-11E5-9242-09173F13E4C5
n5:logP
n6:271B4057-363D-11E5-9242-09173F13E4C5 n6:271B405A-363D-11E5-9242-09173F13E4C5
n5:logS
n6:271B4058-363D-11E5-9242-09173F13E4C5
n5:H-Bond-Acceptor-Count
n6:271B4067-363D-11E5-9242-09173F13E4C5
n5:H-Bond-Donor-Count
n6:271B4068-363D-11E5-9242-09173F13E4C5
n5:InChIKey
n6:271B4062-363D-11E5-9242-09173F13E4C5
n5:Polar-Surface-Area--PSA-
n6:271B4063-363D-11E5-9242-09173F13E4C5
n5:Polarizability
n6:271B4065-363D-11E5-9242-09173F13E4C5
n5:Refractivity
n6:271B4064-363D-11E5-9242-09173F13E4C5
n5:Rotatable-Bond-Count
n6:271B4066-363D-11E5-9242-09173F13E4C5
n5:Bioavailability
n6:271B406D-363D-11E5-9242-09173F13E4C5
n5:Ghose-Filter
n6:271B406F-363D-11E5-9242-09173F13E4C5
n5:MDDR-Like-Rule
n6:271B4070-363D-11E5-9242-09173F13E4C5
n5:Number-of-Rings
n6:271B406C-363D-11E5-9242-09173F13E4C5
n5:Physiological-Charge
n6:271B406B-363D-11E5-9242-09173F13E4C5
n5:Rule-of-Five
n6:271B406E-363D-11E5-9242-09173F13E4C5
n5:Traditional-IUPAC-Name
n6:271B405C-363D-11E5-9242-09173F13E4C5
n5:pKa--strongest-acidic-
n6:271B4069-363D-11E5-9242-09173F13E4C5
n5:pKa--strongest-basic-
n6:271B406A-363D-11E5-9242-09173F13E4C5